To remember
- Treatment with long-acting injectable antipsychotics (LPIs) does not appear to prevent more treatment discontinuations or offer an advantage over oral medications in patients with early-stage schizophrenia.
Why is this important?
- Discuss API antipsychotic therapy with patients to determine if the benefits (maintenance of cognitive function, reduction in suicides, decreased risk of rehospitalization) outweigh the need for monthly injections.
